Regenerative Ocular Immunobiologics Llc
Clinical trials sponsored by Regenerative Ocular Immunobiologics Llc, explained in plain language.
-
New eye drop could ease chronic GVHD dry eye symptoms
Disease control Recruiting nowThis early-phase study tests whether an eye drop called d-MAPPS is safe and can help relieve dry eye symptoms caused by chronic graft-versus-host disease (oGVHD), a complication after stem cell transplant. One adult participant will receive either the active drop or a placebo, an…
Phase: PHASE1, PHASE2 • Sponsor: Regenerative Ocular Immunobiologics LLC • Aim: Disease control
Last updated May 17, 2026 11:58 UTC
-
New hope for chronic eye GVHD: expanded access to d-MAPPS eye drops
Disease control AVAILABLEThis program provides early access to an investigational eye drop called d-MAPPS for people suffering from chronic ocular Graft-Versus-Host Disease (oGVHD), a painful eye condition that can occur after a stem cell or bone marrow transplant. It is for adults aged 18 and older who …
Sponsor: Regenerative Ocular Immunobiologics LLC • Aim: Disease control
Last updated May 11, 2026 20:49 UTC